Literature DB >> 32451496

Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.

Rajagopal Murugan1, Stephen W Scally2,3, Giulia Costa4, Ghulam Mustafa1, Elaine Thai2,5, Tizian Decker1, Alexandre Bosch2, Katherine Prieto2, Elena A Levashina6, Jean-Philippe Julien7,8,9, Hedda Wardemann10.   

Abstract

The circumsporozoite protein of the human malaria parasite Plasmodium falciparum (PfCSP) is the main target of antibodies that prevent the infection and disease, as shown in animal models. However, the limited efficacy of the PfCSP-based vaccine RTS,S calls for a better understanding of the mechanisms driving the development of the most potent human PfCSP antibodies and identification of their target epitopes. By characterizing 200 human monoclonal PfCSP antibodies induced by sporozoite immunization, we establish that the most potent antibodies bind around a conserved (N/D)PNANPN(V/A) core. High antibody affinity to the core correlates with protection from parasitemia in mice and evolves around the recognition of NANP motifs. The data suggest that the rational design of a next-generation PfCSP vaccine that elicits high-affinity antibody responses against the core epitope will promote the induction of protective humoral immune responses.

Entities:  

Year:  2020        PMID: 32451496     DOI: 10.1038/s41591-020-0881-9

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  21 in total

1.  A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver.

Authors:  Lawrence T Wang; Lais S Pereira; Yevel Flores-Garcia; James O'Connor; Barbara J Flynn; Arne Schön; Nicholas K Hurlburt; Marlon Dillon; Annie S P Yang; Amanda Fabra-García; Azza H Idris; Bryan T Mayer; Monica W Gerber; Raphael Gottardo; Rosemarie D Mason; Nicole Cavett; Reid B Ballard; Neville K Kisalu; Alvaro Molina-Cruz; Jorgen Nelson; Rachel Vistein; Carolina Barillas-Mury; Rogerio Amino; David Baker; Neil P King; Robert W Sauerwein; Marie Pancera; Ian A Cockburn; Fidel Zavala; Joseph R Francica; Robert A Seder
Journal:  Immunity       Date:  2020-09-17       Impact factor: 31.745

2.  The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria.

Authors:  Lawrence T Wang; Nicholas K Hurlburt; Arne Schön; Barbara J Flynn; Yevel Flores-Garcia; Lais S Pereira; Patience K Kiyuka; Marlon Dillon; Brian Bonilla; Fidel Zavala; Azza H Idris; Joseph R Francica; Marie Pancera; Robert A Seder
Journal:  Cell Rep       Date:  2022-02-15       Impact factor: 9.423

3.  Highly protective antimalarial antibodies via precision library generation and yeast display screening.

Authors:  Bailey B Banach; Prabhanshu Tripathi; Lais Da Silva Pereira; Jason Gorman; Thuy Duong Nguyen; Marlon Dillon; Ahmed S Fahad; Patience K Kiyuka; Bharat Madan; Jacy R Wolfe; Brian Bonilla; Barbara Flynn; Joseph R Francica; Nicholas K Hurlburt; Neville K Kisalu; Tracy Liu; Li Ou; Reda Rawi; Arne Schön; Chen-Hsiang Shen; I-Ting Teng; Baoshan Zhang; Marie Pancera; Azza H Idris; Robert A Seder; Peter D Kwong; Brandon J DeKosky
Journal:  J Exp Med       Date:  2022-06-23       Impact factor: 17.579

4.  Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies.

Authors:  Sven Kratochvil; Chen-Hsiang Shen; Ying-Cing Lin; Kai Xu; Usha Nair; Lais Da Silva Pereira; Prabhanshu Tripathi; Johan Arnold; Gwo-Yu Chuang; Eleonora Melzi; Arne Schön; Baoshan Zhang; Marlon Dillon; Brian Bonilla; Barbara J Flynn; Kathrin H Kirsch; Neville K Kisalu; Patience K Kiyuka; Tracy Liu; Li Ou; Marie Pancera; Reda Rawi; Mateo Reveiz; Kareen Seignon; Lawrence T Wang; Michael T Waring; John Warner; Yongping Yang; Joseph R Francica; Azza H Idris; Robert A Seder; Peter D Kwong; Facundo D Batista
Journal:  Immunity       Date:  2021-11-16       Impact factor: 43.474

5.  Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11.

Authors:  Iga Kucharska; Elaine Thai; Ananya Srivastava; John L Rubinstein; Régis Pomès; Jean-Philippe Julien
Journal:  Elife       Date:  2020-11-30       Impact factor: 8.140

6.  Malaria vaccine research & innovation: the intersection of IA2030 and zero malaria.

Authors:  David C Kaslow
Journal:  NPJ Vaccines       Date:  2020-11-20       Impact factor: 7.344

7.  Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum.

Authors:  Tossapol Pholcharee; David Oyen; Yevel Flores-Garcia; Gonzalo Gonzalez-Paez; Zhen Han; Katherine L Williams; Wayne Volkmuth; Daniel Emerling; Emily Locke; C Richter King; Fidel Zavala; Ian A Wilson
Journal:  Nat Commun       Date:  2021-02-16       Impact factor: 14.919

8.  A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity.

Authors:  Elaine Thai; Giulia Costa; Anna Weyrich; Rajagopal Murugan; David Oyen; Yevel Flores-Garcia; Katherine Prieto; Alexandre Bosch; Angelo Valleriani; Nicholas C Wu; Tossapol Pholcharee; Stephen W Scally; Ian A Wilson; Hedda Wardemann; Jean-Philippe Julien; Elena A Levashina
Journal:  J Exp Med       Date:  2020-11-02       Impact factor: 14.307

9.  In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).

Authors:  Merricka C Livingstone; Alexis A Bitzer; Alish Giri; Kun Luo; Rajeshwer S Sankhala; Misook Choe; Xiaoyan Zou; S Moses Dennison; Yuanzhang Li; William Washington; Viseth Ngauy; Georgia D Tomaras; M Gordon Joyce; Adrian H Batchelor; Sheetij Dutta
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.996

10.  Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria.

Authors:  Joseph R Francica; Wei Shi; Gwo-Yu Chuang; Steven J Chen; Lais Da Silva Pereira; S Katie Farney; Barbara J Flynn; Li Ou; Tyler Stephens; Yaroslav Tsybovsky; Lawrence T Wang; Alexander Anderson; Zoltan Beck; Marlon Dillon; Azza H Idris; Nicholas Hurlburt; Tracy Liu; Baoshan Zhang; Carl R Alving; Gary R Matyas; Marie Pancera; John R Mascola; Peter D Kwong; Robert A Seder
Journal:  Vaccines (Basel)       Date:  2021-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.